Pediatric patients with pre-existing conditions such as congenital kidney anomalies, chronic kidney disease, or those who have undergone kidney transplants are at higher risk. Monitoring is also crucial for children receiving multiple nephrotoxic drugs or those undergoing prolonged treatment courses.
